SCHEMBL5655596

SCHEMBL5655596

COC(=O)c1cc(OC)c(OC)c2oc(CCl)cc12

nearest known ligand 0.48

Predicted protein targets (top 20)

geneUniProtsupporting neighboursconfidence
KDM4E B2RXH2 7/20 0.48
POLB P06746 3/20 0.48
USP2 O75604 1/20 0.45
HSD17B10 Q99714 1/20 0.45
CA12 O43570 2/20 0.40
CA1 P00915 2/20 0.40
CA7 P43166 2/20 0.40
CA9 Q16790 2/20 0.40
CA13 Q8N1Q1 2/20 0.40
CA2 P00918 1/20 0.40
PDE4A P27815 2/20 0.39
PDE4B Q07343 2/20 0.39
PDE4C Q08493 2/20 0.39
PDE4D Q08499 2/20 0.39
HPGD P15428 2/20 0.39
GAA P10253 2/20 0.38
RELA Q04206 1/20 0.37
ALDH1A1 P00352 4/20 0.37
L3MBTL1 Q9Y468 1/20 0.37
MEN1 O00255 1/20 0.37

Click a target to see other patent compounds predicted against it — the reverse direction, in place.

Similar compounds — the chemically nearest patent molecules

Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.

Compoundsimilaritytop predictedshared targets
SCHEMBL5658621 0.88 KDM4E (0.49) KDM4EPOLBUSP2HSD17B10CA12
SCHEMBL5659653 0.84 PDE4A (0.50) KDM4EPOLBUSP2HSD17B10CA12
SCHEMBL5656372 0.82 KDM4E (0.44) KDM4EPOLBUSP2HSD17B10CA12
SCHEMBL5657720 0.81 KDM4E (0.46) KDM4EPOLBUSP2HSD17B10PDE4B
SCHEMBL5657121 0.80 MEN1 (0.43) KDM4EPOLBUSP2HSD17B10HPGD
SCHEMBL5669321 0.80 KDM4E (0.49) KDM4EPOLBUSP2HSD17B10CA12
SCHEMBL5659101 0.79 SMN1; SMN2 (0.46) KDM4EPOLBUSP2HSD17B10ALDH1A1
SCHEMBL5659515 0.79 KDM4E (0.41) KDM4EPOLBUSP2HSD17B10CA12
SCHEMBL5659291 0.78 MEN1 (0.41) KDM4EPOLBHPGDALDH1A1MEN1
SCHEMBL5657737 0.78 PDE4B (0.46) KDM4EPOLBUSP2HSD17B10PDE4B

Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.

Patent provenance — the patents this molecule appears in, and who filed them

Claimed or disclosed in 5 patents. claimed = in the patent's claims; disclosed = body only.

PatentTitleAssigneePublishedPriorityFilingCountryStatus
US-7030130-B2 Benzofuran derivatives and their use as antibacterial agents ARPIDA AG (CH) 2006-04-18 US disclosed
EP-1307445-B1 BENZOFURAN DERIVATIVES AND THEIR USE AS ANTIBACTERIAL AGENTS ARPIDA AG (CH) 2005-12-21 EP disclosed
US-20040034047-A1 Benzofuran derivatives and their use as antibacterial agents EVOLVA SA (CH) 2004-02-19 US disclosed
EP-1307445-A1 BENZOFURAN DERIVATIVES AND THEIR USE AS ANTIBACTERIAL AGENTS Arpida AG, (CH) 2003-05-07 EP disclosed
WO-2002010157-A1 BENZOFURAN DERIVATIVES AND THEIR USE AS ANTIBACTERIAL AGENTS ARPIDA AG (CH) 2002-02-07 WO disclosed

Patent text — is the patent's own abstract consistent with the prediction?

For each of this compound's patents that has machine-readable text (1 of them — usually the abstract, not the full specification), we ask MedCPT which protein the text reads most about, and where the chemistry-predicted target lands among 4885 human targets. A high rank means the patent's own wording is consistent with the prediction — a weak, independent signal, not proof of activity.

PatentTitleText reads most aboutPredicted target · text-rank
US-20040034047-A1 Benzofuran derivatives and their use as antibacterial agents SBDS, BPTF, DCXR KDM4E 1540/4885POLB 731/4885USP2 3730/4885

“Text reads most about” is the patent abstract's nearest protein in MedCPT space (background-debiased). Only ~1.4% of patents have machine-readable text, so most compounds won't have this panel.